申请人:Aranyi Peter
公开号:US20080146604A1
公开(公告)日:2008-06-19
The present invention relates to adenosine A
3
receptor ligands of the general formula (I), within those preferably antagonists, as well as their salts, solvates and isomers, and the pharmaceutical compositions containing them, to the use of the compounds of the general formula (I), as well as their salts, solvates and isomers, to the preparation of the compounds of the general formula (I) and their salts, solvates and isomers, furthermore to the new intermediates of the general formulae (II) and to the preparation thereof.
本发明涉及通式(I)的腺苷A3受体配体,其中最好是拮抗剂,以及它们的盐、溶剂化物和异构体,以及包含它们的制药组合物,还涉及通式(I)的化合物及其盐、溶剂化物和异构体的使用,以及制备通式(I)的化合物及其盐、溶剂化物和异构体,并涉及通式(II)的新中间体及其制备。